why choose us

First received: July 8, 2022

Clinical Trial: A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects

Study Status: Completed

Recruit Status: Completed

Condition: Type 2 Diabetes

Study Type: Interventional


Official Title: Pharmacokinetics, Safety and Immunogenicity of 14028 Injection Versus Dulaglutide Injection in Healthy Subjects: a Phase I ?Single-center, Randomized, Open-label, Single-dose, Parallel-controlled Clin

Brief Summary: To evaluate the pharmacokinetics similarity between the 14028 injection produced by Sunshine Lake Pharma Co., Ltd. and dulaglutide injection (TRULICITY®) produced by Eli Lilly and Company for single dose in healthy male subjects, as well as to evaluate the similarity of the safety and immunogenicity between 14028 Injection and TRULICITY® in Healthy Subjects

Read more